EyePoint Pharmaceuticals Inc (EYPT)
19.74
-0.20
(-1.00%)
USD |
NASDAQ |
May 03, 16:00
13.75
-5.99
(-30.34%)
After-Hours: 07:44
EyePoint Pharmaceuticals Market Cap: 983.66M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 983.66M |
| May 02, 2024 | 993.63M |
| May 01, 2024 | 898.95M |
| April 30, 2024 | 877.02M |
| April 29, 2024 | 878.52M |
| April 26, 2024 | 834.67M |
| April 25, 2024 | 805.27M |
| April 24, 2024 | 820.71M |
| April 23, 2024 | 875.53M |
| April 22, 2024 | 844.63M |
| April 19, 2024 | 879.51M |
| April 18, 2024 | 872.04M |
| April 17, 2024 | 1.043B |
| April 16, 2024 | 1.088B |
| April 15, 2024 | 1.060B |
| April 12, 2024 | 1.119B |
| April 11, 2024 | 1.141B |
| April 10, 2024 | 1.082B |
| April 09, 2024 | 1.073B |
| April 08, 2024 | 1.033B |
| April 05, 2024 | 1.011B |
| April 04, 2024 | 1.004B |
| April 03, 2024 | 1.034B |
| April 02, 2024 | 1.011B |
| April 01, 2024 | 1.010B |
| Date | Value |
|---|---|
| March 28, 2024 | 1.030B |
| March 27, 2024 | 1.037B |
| March 26, 2024 | 1.028B |
| March 25, 2024 | 1.081B |
| March 22, 2024 | 1.109B |
| March 21, 2024 | 1.167B |
| March 20, 2024 | 1.164B |
| March 19, 2024 | 1.101B |
| March 18, 2024 | 1.061B |
| March 15, 2024 | 1.070B |
| March 14, 2024 | 1.083B |
| March 13, 2024 | 1.101B |
| March 12, 2024 | 1.137B |
| March 11, 2024 | 1.140B |
| March 08, 2024 | 1.216B |
| March 07, 2024 | 1.261B |
| March 06, 2024 | 1.283B |
| March 05, 2024 | 1.274B |
| March 04, 2024 | 1.291B |
| March 01, 2024 | 1.395B |
| February 29, 2024 | 1.334B |
| February 28, 2024 | 1.358B |
| February 27, 2024 | 1.406B |
| February 26, 2024 | 1.302B |
| February 23, 2024 | 1.302B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
51.06M
Minimum
Oct 28 2020
1.457B
Maximum
Feb 12 2024
303.28M
Average
236.49M
Median
Jul 30 2021
Market Cap Benchmarks
| INVO Bioscience Inc | 2.537M |
| Bio-Path Holdings Inc | 1.772M |
| Ocular Therapeutix Inc | 917.03M |
| Aileron Therapeutics Inc | 63.43M |
| Apellis Pharmaceuticals Inc | 5.723B |
Market Cap Related Metrics
| PS Ratio | 16.69 |
| Price to Book Value | 3.694 |
| Price | 19.74 |
| Earnings Yield | -9.22% |